Fiche publication


Date publication

mars 2021

Journal

Anticancer research

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DEBREUVE-THERESETTE Adeline


Tous les auteurs :
Marchand-Crety C, Pascard M, Debreuve-Theresette A, Ettalhaoui L, Schvartz C, Zalzali M, Brugel M, Bellefqih S, Servagi-Vernat S

Résumé

Anaplastic thyroid carcinoma (ATC) is the least common but most lethal of thyroid cancer, despite various therapeutic options, with limited efficacy. In order to help therapeutic decision-making, the purpose of this study was to develop a new prognostic score providing survival estimates in patients with ATC.

Mots clés

Anaplastic thyroid carcinoma, clinical decision-making, prognosis, propensity score, survival

Référence

Anticancer Res. 2021 Mar;41(3):1555-1561